SCHEMBL31069697

SCHEMBL31069697

CCCN(CCC)CCCNC(=O)c1ccc2c(Cl)c3c(nc2c1)CCCC3

nearest known ligand 0.96

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.96
KMT2A Q03164 5/20 0.96
SMN1; SMN2 Q16637 3/20 0.88
TP53 P04637 2/20 0.88
HTT P42858 1/20 0.88
USP7 Q93009 4/20 0.77
GAA P10253 1/20 0.68
GFER P55789 1/20 0.68
MAPT P10636 6/20 0.67
NPC1 O15118 2/20 0.67
RAB9A P51151 2/20 0.67
ALDH1A1 P00352 1/20 0.67
USP10 Q14694 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2218102 1.00 MEN1 (0.96) MEN1KMT2ASMN1; SMN2TP53HTT
SCHEMBL31069695 1.00 MEN1 (0.96) MEN1KMT2ASMN1; SMN2TP53HTT
SCHEMBL2219373 0.94 KMT2A (0.86) MEN1KMT2ASMN1; SMN2TP53HTT
SCHEMBL2218247 0.93 SMN1; SMN2 (1.00) MEN1KMT2ASMN1; SMN2TP53HTT
SCHEMBL2219477 0.89 KMT2A (0.96) MEN1KMT2ASMN1; SMN2TP53HTT
SCHEMBL2221128 0.87 SMN1; SMN2 (0.89) MEN1KMT2ASMN1; SMN2TP53HTT
SCHEMBL2221299 0.87 USP7 (1.00) MEN1KMT2ASMN1; SMN2TP53HTT
SCHEMBL2217604 0.85 SMN1; SMN2 (0.75) MEN1KMT2ASMN1; SMN2TP53HTT
SCHEMBL31069694 0.85 USP7 (0.97) MEN1KMT2ASMN1; SMN2TP53HTT
SCHEMBL15988176 0.84 MEN1 (0.70) MEN1KMT2ASMN1; SMN2TP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024210503-A1 COMPOSITION CONTAINING USP10 INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF OBESITY AND LIPID-RELATED METABOLIC DISEASES 연세대학교 산학협력단 2024-10-10 WO disclosed